| Lycia Therapeutics Raises $75 Million in Oversubscribed Financing and Strengthens Leadership Team with Appointment of Chief Financial Officer and General Counsel |
Globe Newswire |
06/25 |
07:30 |
| NuCube Energy to Become a Publicly Listed Company Through Business Combination with Launch Two Acquisition Corp. |
Globe Newswire |
06/25 |
07:20 |
| Digital Currency X Technology Enters Into Securities Purchase Agreement for a Private Placement of US$700 Million of Units, Payable in U.S. Dollars or Digital Assets, to Advance Its Digital Asset Treasury Strategy |
Globe Newswire |
06/25 |
07:18 |
| Winnebago Industries Reports Third Quarter Fiscal 2026 Results |
Globe Newswire |
06/25 |
07:00 |
| Troilus Drills 157.5 Metres Grading 0.95 g/t AuEq While Targeting Inferred Material Within the Z87 Reserve Pit |
Globe Newswire |
06/25 |
07:00 |
| INmune Bio Inc. Achieves MHRA Approval of PIP for CORDStrom™ |
Globe Newswire |
06/25 |
07:00 |
| Lithium Ionic Advances Construction Readiness at Bandeira; Secures Construction-Phase Water Access and Provides Engineering and Procurement Updates |
Globe Newswire |
06/25 |
07:00 |
| Kymera Therapeutics Completes Enrollment in the Phase 2b BROADEN2 Trial of KT-621 in Atopic Dermatitis with Topline Data by Year-end 2026 |
Globe Newswire |
06/25 |
07:00 |
| Highlander Silver: Comprehensive Geophysical Program Maps Extensive System Concealed by Shallow Cover at Corani |
Globe Newswire |
06/25 |
07:00 |
| Tiziana Announces Last Patient Successfully Dosed in its Phase 2 INFORM-MS Trial |
Globe Newswire |
06/25 |
07:00 |
| Initial Lightbridge Fuel™ Material Samples Removed from Idaho National Laboratory’s Advanced Test Reactor |
Globe Newswire |
06/25 |
07:00 |
| Seres Therapeutics to Host Webcast on July 8, 2026, to Discuss Results of Investigator-Sponsored Trial of Seres’ SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis |
Globe Newswire |
06/25 |
07:00 |
| GDS Concludes Successful 2026 Annual General Meeting with All Resolutions Passed, Including Election and Re-election of Directors |
Globe Newswire |
06/25 |
07:00 |
| Atea Pharmaceuticals Completes Patient Enrollment in Phase 3 C-FORWARD Trial Evaluating Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus |
Globe Newswire |
06/25 |
07:00 |
| AnaCardio´s Phase 1b/2a GOAL-HF1 study in patients with Heart Failure and Reduced Ejection Fraction (HFrEF) published in The Lancet |
Globe Newswire |
06/25 |
07:00 |
| Baker Hughes to Deliver Subsea Production Systems to Support Azule Energy’s Greater PAJ Development |
Globe Newswire |
06/25 |
07:00 |
| Autolus Therapeutics to Participate in Upcoming Investor Conference |
Globe Newswire |
06/25 |
07:00 |
| Treno Scope Launches “Data for All” Initiative, Empowering Developers in Vietnam and Thailand |
Globe Newswire |
06/25 |
06:55 |
| ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement |
Globe Newswire |
06/25 |
06:35 |
| WeRide GENESIS Named “Generative AI Platform of the Year,” Following ATTI Simulation Innovation Award |
Globe Newswire |
06/25 |
06:25 |
| ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform |
Globe Newswire |
06/25 |
06:25 |
| Bunker Hill Mining on Track for Concentrate Production by the End of the Month |
Globe Newswire |
06/25 |
06:15 |
| DeepHealth Receives Two FDA Clearances Enabling it to Add Cardiovascular Insights and Prior Exam Integration to its AI-Powered Breast Suite |
Globe Newswire |
06/25 |
06:00 |
| BrewDog Inverurie Reopens with New Community Champions Model |
Globe Newswire |
06/25 |
06:00 |
| Beam Global Relocates Manufacturing Operations to Yuma, AZ |
Globe Newswire |
06/25 |
06:00 |
